Remission of ulcerative colitis flare-up induced by nivolumab
ConclusionThe administration of ICI for UC is not as yet sufficiently safe and further research is required.
Source: International Journal of Colorectal Disease - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Colon Cancer | Colorectal Cancer | CT Scan | Diarrhoea | Endoscopy | Gastroenterology | Inflammatory Bowel Disease | Kidney Cancer | Prednisolone | Renal Cell Carcinoma | Ulcerative Colitis